Nattawat Klomjit

835 total citations
31 papers, 461 citations indexed

About

Nattawat Klomjit is a scholar working on Surgery, Nephrology and Genetics. According to data from OpenAlex, Nattawat Klomjit has authored 31 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 11 papers in Nephrology and 9 papers in Genetics. Recurrent topics in Nattawat Klomjit's work include Renal Diseases and Glomerulopathies (10 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Tissue Engineering and Regenerative Medicine (4 papers). Nattawat Klomjit is often cited by papers focused on Renal Diseases and Glomerulopathies (10 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Tissue Engineering and Regenerative Medicine (4 papers). Nattawat Klomjit collaborates with scholars based in United States, Canada and Lebanon. Nattawat Klomjit's co-authors include Ladan Zand, Fernando C. Fervenza, Patompong Ungprasert, Mariam P. Alexander, Samih H. Nasr, Ziad Zoghby, Marie C. Hogan, Amir Lerman, Lilach O. Lerman and Nelson Leung and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and Hypertension.

In The Last Decade

Nattawat Klomjit

26 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nattawat Klomjit United States 11 227 113 105 102 94 31 461
Johnny Sayegh France 15 134 0.6× 205 1.8× 47 0.4× 45 0.4× 163 1.7× 34 661
Calogero Lino Cirami Italy 12 133 0.6× 131 1.2× 46 0.4× 52 0.5× 59 0.6× 37 499
William Morello Italy 12 118 0.5× 71 0.6× 197 1.9× 44 0.4× 89 0.9× 38 581
Fengfeng Xu China 9 169 0.7× 81 0.7× 138 1.3× 38 0.4× 63 0.7× 11 416
K.-H. Shu Taiwan 12 144 0.6× 149 1.3× 85 0.8× 50 0.5× 87 0.9× 38 493
Go Kanzaki Japan 17 390 1.7× 83 0.7× 178 1.7× 17 0.2× 179 1.9× 61 742
Takeshi Fujita Japan 12 86 0.4× 74 0.7× 97 0.9× 21 0.2× 68 0.7× 47 421
Smaragdi Marinaki Greece 12 108 0.5× 40 0.4× 50 0.5× 83 0.8× 170 1.8× 53 462
Kikuo Iitaka Japan 14 343 1.5× 68 0.6× 81 0.8× 17 0.2× 122 1.3× 58 533
Purva Sharma United States 8 190 0.8× 130 1.2× 76 0.7× 283 2.8× 131 1.4× 22 506

Countries citing papers authored by Nattawat Klomjit

Since Specialization
Citations

This map shows the geographic impact of Nattawat Klomjit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nattawat Klomjit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nattawat Klomjit more than expected).

Fields of papers citing papers by Nattawat Klomjit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nattawat Klomjit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nattawat Klomjit. The network helps show where Nattawat Klomjit may publish in the future.

Co-authorship network of co-authors of Nattawat Klomjit

This figure shows the co-authorship network connecting the top 25 collaborators of Nattawat Klomjit. A scholar is included among the top collaborators of Nattawat Klomjit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nattawat Klomjit. Nattawat Klomjit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klomjit, Nattawat, Michael D. Evans, Maria Vargas, et al.. (2025). The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy. Kidney International. 108(2). 271–282. 1 indexed citations
2.
Herrmann, Sandra M., Ala Abudayyeh, Shruti Gupta, et al.. (2024). Diagnosis and management of immune checkpoint inhibitor–associated nephrotoxicity: a position statement from the American Society of Onco-nephrology. Kidney International. 107(1). 21–32. 12 indexed citations
3.
Karam, Sabine, et al.. (2024). Case report: Successful treatment of renal-limited thrombotic microangiopathy secondary to chronic lymphocytic leukemia. SHILAP Revista de lepidopterología. 4. 1400027–1400027.
4.
5.
Klomjit, Nattawat, Ladan Zand, Lynn D. Cornell, & Mariam P. Alexander. (2023). COVID-19 and Glomerular Diseases. Kidney International Reports. 8(6). 1137–1150. 23 indexed citations
6.
Vaughan, Lisa E., et al.. (2023). Monoclonal Gammopathy and Its Association with Progression to Kidney Failure and Mortality in Patients with CKD. Clinical Journal of the American Society of Nephrology. 19(3). 319–328. 4 indexed citations
7.
Zhu, Xiangyang, Nattawat Klomjit, Aditya S. Pawar, et al.. (2023). Altered immune cell phenotypes within chronically ischemic human kidneys distal to occlusive renal artery disease. American Journal of Physiology-Renal Physiology. 326(2). F257–F264. 5 indexed citations
8.
Klomjit, Nattawat, Xiangyang Zhu, Alfonso Eirin, et al.. (2022). Microvascular remodeling and altered angiogenic signaling in human kidneys distal to occlusive atherosclerotic renal artery stenosis. Nephrology Dialysis Transplantation. 37(10). 1844–1856. 10 indexed citations
9.
Yu, Shasha, Nattawat Klomjit, Kai Jiang, et al.. (2022). Human Obesity Attenuates Cardioprotection Conferred by Adipose Tissue–Derived Mesenchymal Stem/Stromal Cells. Journal of Cardiovascular Translational Research. 16(1). 221–232. 5 indexed citations
10.
Klomjit, Nattawat & Patompong Ungprasert. (2022). Acute kidney injury associated with non-steroidal anti-inflammatory drugs. European Journal of Internal Medicine. 101. 21–28. 53 indexed citations
11.
Klomjit, Nattawat, Sabena M. Conley, Xiang Zhu, et al.. (2022). Effects of obesity on reparative function of human adipose tissue-derived mesenchymal stem cells on ischemic murine kidneys. International Journal of Obesity. 46(6). 1222–1233. 13 indexed citations
12.
Klomjit, Nattawat, Mariam P. Alexander, Fernando C. Fervenza, et al.. (2021). COVID-19 Vaccination and Glomerulonephritis. Kidney International Reports. 6(12). 2969–2978. 134 indexed citations
13.
Klomjit, Nattawat, Mireille El Ters, Benjamin Adam, et al.. (2021). Diffuse C4d staining of peritubular capillaries in renal allograft following bamlanivimab therapy. American Journal of Transplantation. 22(1). 289–293. 2 indexed citations
14.
Klomjit, Nattawat, Amir Lerman, & Lilach O. Lerman. (2020). It Comes As a Shock. Hypertension. 76(6). 1696–1703. 9 indexed citations
15.
Klomjit, Nattawat, Nelson Leung, Fernando C. Fervenza, Sanjeev Sethi, & Ladan Zand. (2020). Rate and Predictors of Finding Monoclonal Gammopathy of Renal Significance (MGRS) Lesions on Kidney Biopsy in Patients with Monoclonal Gammopathy. Journal of the American Society of Nephrology. 31(10). 2400–2411. 42 indexed citations
16.
Klomjit, Nattawat & Ladan Zand. (2020). Acquired thoracic kidney. Kidney International. 97(4). 811–811.
17.
Singh, Prince, Raymund R. Razonable, Elizabeth C. Lorenz, et al.. (2020). Chronic graft-versus-host disease in pancreas after kidney transplant recipients – An unrecognized entity. American Journal of Transplantation. 21(2). 883–888. 1 indexed citations
18.
Klomjit, Nattawat, Mariam P. Alexander, & Ladan Zand. (2020). Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9). Kidney360. 1(9). 1002–1013. 14 indexed citations
19.
Klomjit, Nattawat, Fernando C. Fervenza, & Ladan Zand. (2020). Successful Treatment of Patients With Refractory PLA2R-Associated Membranous Nephropathy With Obinutuzumab: A Report of 3 Cases. American Journal of Kidney Diseases. 76(6). 883–888. 71 indexed citations
20.
Klomjit, Nattawat, Daniel J. Rowan, Andrea G. Kattah, Irina Bancos, & Sandra J. Taler. (2019). New-Onset Resistant Hypertension in a Newly Diagnosed Prostate Cancer Patient. American Journal of Hypertension. 32(12). 1214–1217. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johnny Sayegh Breakdown of academic impact, for papers by Calogero Lino Cirami Breakdown of academic impact, for papers by William Morello Breakdown of academic impact, for papers by Fengfeng Xu Breakdown of academic impact, for papers by K.-H. Shu Breakdown of academic impact, for papers by Go Kanzaki Breakdown of academic impact, for papers by Takeshi Fujita Breakdown of academic impact, for papers by Smaragdi Marinaki Breakdown of academic impact, for papers by Kikuo Iitaka Breakdown of academic impact, for papers by Purva Sharma
Rankless by CCL
2026